Comparison of myocardial perfusion imaging with Rb82 PET versus Tc-tetrofosmin CZT SPECT in patients with coronary artery disease

Comparison of myocardial perfusion imaging with Rb82 PET versus Tc-tetrofosmin CZT SPECT in patients with coronary artery disease - RubiSPECT

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON42775

Enrollment

185

Registered

2015-09-11

Start date

2015-09-01

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atherosclerotic heart disease ischemic heart disease

Interventions

None listed

Sponsors

Isala, Zwolle

Lead Sponsor

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Have undergone SPECT evaluation CAC >100 Have provided written informed consent

Exclusion criteria

Exclusion criteria: No informed consent obtained Patients with inintolerance of adenosine or regadenoson as stress agents (rare) Unable to undergo PET imaging Age

Design outcomes

Primary

Measure	Time frame
Concordance, discordance, sensitivity and specificity of SPECT and PET	—

Secondary

Measure	Time frame
nvt	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)